1) Thakur C. (2019) An Overview, Current Challenges of Drug Resistance, and Targeting Metastasis Associated with Lung Cancer. Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer.1, 21-38.
2) Sutherland KD, Berns A. (2010) Cell of origin of lung cancer. Molecular oncology. 4, 397-403.
3) Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 71, 209-49.
4) Salmenkivi K, Knuuttila A. (2014) Diagnostics of non-small cell lung carcinoma. Duodecim; laaketieteellinen aikakauskirja. 130,701-4.
5) Rosenzweig K. (2017) Stereotactic Body Radiation Therapy as an Alternative to Surgery in Early-Stage Non-Small-Cell Lung Cancer. Oncology (08909091). 31,492-498
6) Wan Y, Yuan Y, Pan Y, Zhang Y. (2017) Antitumor activity of high-dose pulsatile gefitinib in non-small-cell lung cancer with acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors. Experimental and therapeutic medicine.13,3067-74.
7) Zhang K, Yuan Q. (2016) Current mechanism of acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors and updated therapy strategies in human nonsmall cell lung cancer. Journal of cancer research and therapeutics. 12,131-137.
8) Wu L, Wang X, Xu W, Farzaneh F, Xu R. (2009) The structure and pharmacological functions of coumarins and their derivatives. Current medicinal chemistry. 16, 4236-4260.
9) Stefanachi A, Leonetti F, Pisani L, Catto M, Carotti A. (2018) Coumarin: A natural, privileged and versatile scaffold for bioactive compounds. Molecules. 23,250.
10) Ren QC, Gao C, Xu Z, Feng LS, Liu ML, Wu X, Zhao F. (2018) Bis-coumarin derivatives and their biological activities. Current topics in medicinal chemistry. 18,101-13.
11) Lin MH, Cheng CH, Chen KC, Lee WT, Wang YF, Xiao CQ, Lin CW. (2014) Induction of ROS-independent JNK-activation-mediated apoptosis by a novel coumarin-derivative, DMAC, in human colon cancer cells. Chemico-biological interactions. 218, 42-49.
12) Wang G, Lu M, Yao Y, Wang J, Li J. (2017) Esculetin exerts antitumor effect on human gastric cancer cells through IGF-1/PI3K/Akt signaling pathway. European journal of pharmacology. 814,207-215.
13) Musa MA, Cooperwood JS, Khan MO. (2008) A review of coumarin derivatives in pharmacotherapy of breast cancer. Current medicinal chemistry. 15,2664-2679.
14) Zhang H, Feng QQ, Gong JH, Ma JP. (2018) Anticancer effects of isofraxidin against A549 human lung cancer cells via the EGFR signaling pathway. Molecular medicine reports. 18,407-414.
15) Tavakoli S, Delnavazi MR, Hadjiaghaee R, Jafari-Nodooshan S, Khalighi-Sigaroodi F, Akhbari M, Hadjiakhoondi A, Yassa N. (2018) Bioactive coumarins from the roots and fruits of Ferulago trifida Boiss., an endemic species to Iran. Natural product research. 32,2724-2728.
16) Pfeffer CM, Singh AT. (2018) Apoptosis: a target for anticancer therapy. International journal of molecular sciences. 19,448.
17) Choi KS. (2012) Autophagy and cancer. Experimental & molecular medicine. 44,109-120.
18) Su M, Mei Y, Sinha S. (2013) Role of the crosstalk between autophagy and apoptosis in cancer. Journal of oncology. 2013.
19) Elmore S. (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol. 35, 495-516.
20) Fernald K, Kurokawa M. (2013) Evading apoptosis incancer. Trends Cell Biol; 23, 620-33.

21) Kiess W, Gallaher B. (1998) Hormonal control ofprogrammed cell death/apoptosis. Eur J Endocrinol; 138, 482-491.
22) Ashkenazi A, Salvesen G. (2014) Regulated cell death: signaling and mechanisms. Annual review of cell and developmental biology. 30,337-356.
23) Czabotar PE, Lessene G, Strasser A, Adams JM. (2014) Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nature reviews Molecular cell biology. 15,49-63.
24) Nakahira K, Cloonan SM, Mizumura K, Choi AM, Ryter SW. (2014) Autophagy: a crucial moderator of redox balance, inflammation, and apoptosis in lung disease. Antioxidants & redox signaling. 20,474-494.
25) Ren G, Luo W, Sun W, Niu Y, Ma DL, Leung CH, Wang Y, Lu JJ, Chen X. (2016) Psoralidin induced reactive oxygen species (ROS)-dependent DNA damage and protective autophagy mediated by NOX4 in breast cancer cells. Phytomedicine. 23,939-947.
26) Suparji NS, Chan G, Sapili H, Arshad NM, In LL, Awang K, Hasima Nagoor N. (2016) Geranylated 4-Phenylcoumarins exhibit anticancer effects against human prostate cancer cells through caspase-independent mechanism. PloS one. 11.